Correlation Between Schwab Strategic and Franklin Genomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Schwab Strategic and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Schwab Strategic and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Schwab Strategic Trust and Franklin Genomic Advancements, you can compare the effects of market volatilities on Schwab Strategic and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Schwab Strategic with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Schwab Strategic and Franklin Genomic.

Diversification Opportunities for Schwab Strategic and Franklin Genomic

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Schwab and Franklin is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Schwab Strategic Trust and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and Schwab Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Schwab Strategic Trust are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of Schwab Strategic i.e., Schwab Strategic and Franklin Genomic go up and down completely randomly.

Pair Corralation between Schwab Strategic and Franklin Genomic

Given the investment horizon of 90 days Schwab Strategic is expected to generate 1.36 times less return on investment than Franklin Genomic. In addition to that, Schwab Strategic is 3.28 times more volatile than Franklin Genomic Advancements. It trades about 0.02 of its total potential returns per unit of risk. Franklin Genomic Advancements is currently generating about 0.09 per unit of volatility. If you would invest  2,855  in Franklin Genomic Advancements on November 18, 2024 and sell it today you would earn a total of  173.00  from holding Franklin Genomic Advancements or generate 6.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Schwab Strategic Trust  vs.  Franklin Genomic Advancements

 Performance 
       Timeline  
Schwab Strategic Trust 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Schwab Strategic Trust are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Schwab Strategic is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Franklin Genomic Adv 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Genomic Advancements are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Franklin Genomic may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Schwab Strategic and Franklin Genomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Schwab Strategic and Franklin Genomic

The main advantage of trading using opposite Schwab Strategic and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Schwab Strategic position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.
The idea behind Schwab Strategic Trust and Franklin Genomic Advancements pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm